L Lacomblez Selected Research

L Lacomblez Research Topics

6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2014 - 09/2000
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 06/2000
2	Disease Progression 03/2008 - 04/2002
2	Nausea 01/2006 - 01/2002
2	Atrial Fibrillation 01/2001 - 11/2000
1	Nervous System Diseases (Neurological Disorders) 06/2015
1	Facioscapulohumeral Muscular Dystrophy 07/2009
1	Hyperlipidemias (Hyperlipidemia) 03/2008
1	Deglutition Disorders (Dysphagia) 01/2006
1	Flushing 01/2006
1	Fasciculation (Fasciculations) 03/2005
1	Atrophy 03/2005
1	Cough 03/2005
1	Alzheimer Disease (Alzheimer's Disease) 07/2002
1	Dementia (Dementias) 07/2002
1	Disorders of Excessive Somnolence (Hypersomnia) 04/2002
1	Apnea 04/2002
1	Sleepiness 04/2002
1	Asthenia 01/2002
1	Pallidopyramidal syndrome 07/2001
1	Cognitive Dysfunction 01/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2001
1	Hemorrhage 01/2001
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2000
1	Dyskinesias (Dyskinesia) 06/2000
1	Dystonia (Limb Dystonia) 06/2000
1	Paraplegia (Spastic Paraplegia) 06/2000
1	Dopa-responsive Dystonia 06/2000

6	Riluzole FDA LinkGeneric 03/2014 - 12/2000
2	Pharmaceutical PreparationsIBA 06/2015 - 01/2006
2	Levodopa (L Dopa)FDA LinkGeneric 04/2002 - 06/2000
2	fluindioneIBA 01/2001 - 11/2000
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2001 - 11/2000
2	AnticoagulantsIBA 01/2001 - 11/2000
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	olesoximeIBA 03/2014
1	Albuterol (Salbutamol)FDA LinkGeneric 07/2009
1	oxidized low density lipoproteinIBA 03/2008
1	LipidsIBA 03/2008
1	CholesterolIBA 03/2008
1	CreatinineIBA 03/2005
1	Biological ProductsIBA 03/2005
1	Neuroprotective AgentsIBA 05/2002
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2002
1	Apolipoproteins E (ApoE)IBA 04/2002
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2002
1	Transaminases (Aminotransferases)IBA 01/2002
1	Flumazenil (Romazicon)FDA LinkGeneric 07/2001
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2001
1	Free RadicalsIBA 09/2000
1	Guanosine Triphosphate (GTP)IBA 06/2000

1	Ambulatory Care (Outpatient Care) 01/2017
1	Activities of Daily Living (ADL) 07/2002
1	Drug Therapy (Chemotherapy) 04/2002
1	Highly Active Antiretroviral Therapy (HAART) 01/2001
1	Therapeutics 11/2000